Blue Nevus and Blue Nevus-Like Melanoma

A blue nevus (plural nevi) is a specific type of mole that can occur anywhere on the skin. It is called "blue" because its black-brown melanin pigment resides deeper in the skin. This, like a black tattoo, can make them look bluish. While blue nevi are benign, they can rarely transform into a melanoma known as blue nevus-like melanoma or formerly malignant blue nevus.

Signs and Symptoms of Transformation

Typically, it is a longstanding blue nevus that starts changing that should prompt examination and biopsy. Specific warning signs include:

  • Change in a Stable Lesion: Any shift in size, shape, or color in a lesion that has been present for years.
  • Rapid Growth: The sudden appearance of firm, blue-black nodules or a thickened, "plaque-like" area.
  • Texture and Border: Lesions that feel firm to the touch or develop a gelatinous-looking rim.
  • Size: Any blue lesion exceeding 1cm in diameter warrants a professional evaluation.

Diagnosis: To distinguish these from benign blue nevi, a biopsy and histologic examination are required.

How common is blue nevus-like melanoma?

Blue nevus-like melanoma is ultra-rare, accounting for <1% of all melanoma cases. There is no evidence that blue nevi transform to melanoma more or less frequently than common nevi; rather, blue nevi are simply less frequent in the general population. This lower "baseline" frequency of the precursor (the blue nevus) likely explains the rarity of the resulting melanoma.

Biological Relationship to Uveal Melanoma

Blue nevus-like melanoma and uveal (eye) melanoma are biologically closely related, if not identical. They share several defining features:

  • Identical Pathogenic Mutations: Both are driven by mutations in the GNAQ or GNA11 genes, which operate in a different signaling pathway than the BRAF and NRAS mutations commonly found in the much more common melanomas caused by sun-light. The GNAQ or GNA11 cause the blue nevus. Progression to blue nevus-like melanoma occurs through mutations in genes including BAP1, SF3B1, or EIF1AX, similar progression genes as in uveal melanoma.
  • Metastatic Behavior: Both blue nevus-like melanoma and uveal melanoma show a specific biological "tropism" for the liver, which is the most common site of metastasis for patients whose disease progresses.

Because these diseases are virtually identical in their molecular makeup and behavior, they require specialized treatment approaches that differ from standard skin melanoma.

Treatment and Care

  • Surgery: Primary treatment involves removing the tumor with clear margins.
  • Specialized Oncology: Because these tumors often do not respond to the standard immunotherapies used for cutaneous melanoma, patients should see specialists familiar with GNAQ/11 mutated tumors or uveal melanoma. Treatment may include liver-directed therapies or clinical trials specifically targeting these melanoma subtypes.

More to Explore

FAQ

Are blue moles normal?

In most cases, yes. A blue mole, medically known as a blue nevus, is usually a normal and benign skin lesion. Many people have one or more blue nevi, and they often appear during childhood or early adulthood. Although most blue moles are harmless, it is still important to monitor them for any unusual changes. Any mole that grows quickly, changes color or shape, becomes painful, or begins to bleed, should be evaluated by a dermatologist as soon as possible.

Can a blue mole turn into melanoma?

Yes, but this is rare. A blue mole, or blue nevus, is typically a benign lesion that remains stable and harmless throughout a person’s life. However, in uncommon cases melanoma can develop within or from a pre-existing blue nevus, or it may appear as a melanoma that closely resembles one. When this occurs, it is often described medically as blue nevus-associated melanoma or blue nevus-like melanoma.

What is a blue nevus-like melanoma?

Blue nevus-like melanoma is a rare form of melanoma that resembles a blue nevus, either in its appearance on the skin or under the microscope. Because it can look similar to a benign blue nevus, distinguishing between the two can sometimes be challenging. Unlike a benign blue nevus, blue nevus-like melanoma is malignant and has the potential to grow quickly, invade deeper tissues, and spread to other parts of the body. Dermatologists typically recommend a biopsy and detailed pathological examination to confirm the diagnosis.

How do doctors identify blue nevus vs blue nevus-like melanoma?

Doctors usually begin with a skin examination and dermoscopy, a tool that allows them to closely examine the patterns and structures within a mole. Because some lesions can appear very similar, further testing is often needed. In many cases, a biopsy is required to determine whether the lesion is benign or cancerous. During a biopsy, a sample of the mole is removed and examined by a pathologist, often using special staining techniques and molecular tests to confirm whether the lesion is a blue nevus or melanoma.

When should a blue nevus be checked by a doctor?

A blue nevus should be evaluated by a dermatologist if it changes in size, shape, color, or texture, or if it becomes symptomatic - such as causing pain, itching, bleeding, or ulceration. People who have many moles, a personal or family history of melanoma, or other skin cancer risk factors may benefit from regular skin exams. Early evaluation helps ensure that any suspicious lesion is identified and treated as quickly as possible.

Back to Types of Melanoma
Related Content
MRA’s newsletter
Share on social
medical care team icon
Are you a rare melanoma patient or caregiver looking for clinical trial updates or advocacy opportunities?
Get started
scientific researcher in labcommunity hands all together

Help Advance Melanoma Research

By joining MRA’s RARE Registry, you'll be joining a supportive and growing community of patients, advocates, and loved ones who are committed to advancing research into rare melanoma subtypes.

Learn More